focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.50
Bid: 39.00
Ask: 40.00
Change: -1.50 (-3.66%)
Spread: 1.00 (2.564%)
Open: 41.00
High: 41.00
Low: 39.50
Prev. Close: 41.00
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Centaur Media plc

11 Apr 2024 15:15

Aberforth Partners LLP - Form 8 (OPD) - Centaur Media plc

Aberforth Partners LLP - Form 8 (OPD) - Centaur Media plc

PR Newswire

LONDON, United Kingdom, April 11

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Aberforth Partners LLP, on behalf of discretionary clients.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

 

Centaur Media plc

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

 For an opening position disclosure, state the latest practicable date prior to the disclosure

 

10/04/2024

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state “N/A”

YES / NO / N/A NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

Ordinary Shares

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 33,717,126

 

22.959%

 

 

0

 

0.0

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 TOTAL:

 33,717,126

 

22.959%

 

 

0

 

0.0

 

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 10,824,451 shares included in the total disclosed above. This total includes 10,824,451 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors’ and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

N/A- Opening Disclosure

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

 

11 April 2024

 

Contact name:

Michael Campbell, for Aberforth Partners LLP

Telephone number:

0131 220 0733

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 



Date   Source Headline
4th Apr 201612:07 pmRNSHolding(s) in Company
1st Apr 20169:41 amRNSHolding(s) in Company
31st Mar 20165:43 pmRNSDirector/PDMR Shareholding
31st Mar 20162:38 pmRNSHolding(s) in Company
29th Mar 20166:02 pmRNSHolding(s) in Company
29th Mar 20162:42 pmRNSDirector/PDMR Shareholding
29th Mar 20162:38 pmRNSDirector/PDMR Shareholding
24th Mar 20165:21 pmRNSHolding(s) in Company
22nd Mar 201610:32 amRNSDirector/PDMR Shareholding
21st Mar 20164:12 pmRNSDirector/PDMR Shareholding
17th Mar 201611:43 amRNSReplacement RNS : Preliminary Results
17th Mar 20167:00 amRNSPreliminary Results
11th Mar 20164:40 pmRNSSecond Price Monitoring Extn
11th Mar 20164:35 pmRNSPrice Monitoring Extension
2nd Mar 20169:43 amRNSHolding(s) in Company
29th Feb 20169:33 amRNSHolding(s) in Company
22nd Feb 201610:03 amRNSDirector/PDMR Shareholding
12th Feb 20164:24 pmRNSHolding(s) in Company
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
11th Feb 20162:31 pmRNSHolding(s) in Company
10th Feb 201611:36 amRNSHolding(s) in Company
20th Jan 201611:28 amRNSDirector/PDMR Shareholding
14th Jan 20164:41 pmRNSSecond Price Monitoring Extn
14th Jan 20164:35 pmRNSPrice Monitoring Extension
14th Jan 20162:24 pmRNSHolding(s) in Company
11th Jan 20164:40 pmRNSSecond Price Monitoring Extn
11th Jan 20164:35 pmRNSPrice Monitoring Extension
22nd Dec 20153:57 pmRNSHolding(s) in Company
22nd Dec 20153:23 pmRNSDirector/PDMR Shareholding
21st Dec 20155:17 pmRNSHolding(s) in Company
10th Dec 20159:08 amRNSHolding(s) in Company
9th Dec 201512:01 pmRNSHolding(s) in Company
9th Dec 201510:34 amRNSHolding(s) in Company
3rd Dec 201511:18 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSHolding(s) in Company
20th Nov 20153:26 pmRNSDirector/PDMR Shareholding
18th Nov 20154:23 pmRNSDirector/PDMR Shareholding
12th Nov 201512:10 pmRNSHolding(s) in Company
11th Nov 20157:00 amRNSTrading Statement
28th Oct 20155:44 pmRNSDirector/PDMR Shareholding
20th Oct 201511:59 amRNSDirector/PDMR Shareholding
23rd Sep 20151:54 pmRNSDirector/PDMR Shareholding
19th Aug 20154:40 pmRNSSecond Price Monitoring Extn
19th Aug 20154:35 pmRNSPrice Monitoring Extension
19th Aug 20154:27 pmRNSDirector/PDMR Shareholding
30th Jul 20157:00 amRNSInterim Results
20th Jul 20155:19 pmRNSDirector/PDMR Shareholding
16th Jul 201510:12 amRNSNotice of Interim Results
15th Jul 20157:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.